Publications by authors named "Jonathon Golas"

Claim this Profile
A
A Novel B7-H4xCD3 Bispecific T-cell Engager (PF-07260437) Synergizes with Breast Cancer Standard of Care and Immune Checkpoint Therapies.
Keith Abayasiriwardana, Lei Wu, Hanane Laklai, Malgorzata Nocula-Lugowska, Lioudmila Tchistiakova, Jonathon Golas

Mol Cancer Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of EDB Fibronectin in Plasma, Patient-Derived Xenograft Formalin-Fixed Paraffin-Embedded and Fresh Frozen Tumor Tissues Using Immunoaffinity LC-MS/MS.
Fengping Li, Andrea T Hooper, Jonathon Golas, Chao-Pei Betty Chang, Hendrik Neubert

J Proteome Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-Extra Domain B Splice Variant of Fibronectin Antibody-Drug Conjugate Eliminates Tumors with Enhanced Efficacy When Combined with Checkpoint Blockade.
Andrea T Hooper, Kimberly Marquette, Chao-Pei Betty Chang, Jonathon Golas, Sadhana Jain

Mol Cancer Ther· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NOTCH3-targeted antibody drug conjugates regress tumors by inducing apoptosis in receptor cells and through transendocytosis into ligand cells.
Kenneth G Geles, Yijie Gao, Andreas Giannakou, Latha Sridharan, Ting-Ting Yamin, Jonathon Golas

Cell Rep Med· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PF-06804103, A Site-specific Anti-HER2 Antibody-Drug Conjugate for the Treatment of HER2-expressing Breast, Gastric, and Lung Cancers.
Edmund I Graziani, Matthew Sung, Dangshe Ma, Bitha Narayanan, Kimberly Marquette, Jonathon Golas

Mol Cancer Ther· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression.
Shuang Chen, Andreas Giannakou, Jonathon Golas, Kenneth G Geles

J Vis Exp· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-associated fibroblasts suppress SOX2-induced dysplasia in a lung squamous cancer coculture.
Shuang Chen, Andreas Giannakou, Sarah Wyman, Janet Gruzas, Jonathon Golas

Proc Natl Acad Sci U S A· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reciprocal regulation of amino acid import and epigenetic state through Lat1 and EZH2.
Stephen G Dann, Michael Ryskin, Anthony M Barsotti, Jonathon Golas, Celine Shi

EMBO J· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic reprogramming by tumor-derived EZH2 gain-of-function mutations promotes aggressive 3D cell morphologies and enhances melanoma tumor growth.
Anthony M Barsotti, Michael Ryskin, Wenyan Zhong, Wei-Guo Zhang, Andreas Giannakou, Jonathon Golas

Oncotarget· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term tumor regression induced by an antibody-drug conjugate that targets 5T4, an oncofetal antigen expressed on tumor-initiating cells.
Puja Sapra, Marc Damelin, John Dijoseph, Kimberly Marquette, Kenneth G Geles, Jonathon Golas

Mol Cancer Ther· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delineation of a cellular hierarchy in lung cancer reveals an oncofetal antigen expressed on tumor-initiating cells.
Marc Damelin, Kenneth G Geles, Maximillian T Follettie, Ping Yuan, Michelle Baxter, Jonathon Golas

Cancer Res· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis